Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Diseases × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 41 Myelodysplastic Syndromes 18 Breast Neoplasms 18 Leukemia, Myelomonocytic, Chronic 12 Prostatic Neoplasms 10 Neoplasms 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Myeloproliferative Disorders 5 Multiple Myeloma 5 Lymphoma, B-Cell 5 Esophageal Neoplasms 5 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Melanoma 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3 Squamous Cell Carcinoma of Head and Neck 3 Primary Myelofibrosis 3 Polycythemia Vera 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

Sorafenib 4 Blood Specimen Collection 4 lenvatinib 2 halofantrine 2 camrelizumab 2 Liver Transplantation 2 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 sintilimab 1 pembrolizumab 1 ledipasvir, sofosbuvir drug combination 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 bavituximab 1 atezolizumab 1 User-Centered Design 1 Sunitinib 1 Sufentanil 1 Sofosbuvir 1 Ropivacaine 1 Ribavirin 1 Radiotherapy 1 Radiosurgery 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Patient Navigation 1 Nutritional Status 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡